BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8251913)

  • 1. The detection of post-therapy residual minimal disease in leukemias characterized by specific chromosomal anomalies.
    Fuscaldo KE; Brodsky I
    Leuk Lymphoma; 1993; 11 Suppl 1():33-7. PubMed ID: 8251913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction.
    Drexler HG; Borkhardt A; Janssen JW
    Leuk Lymphoma; 1995 Nov; 19(5-6):359-80. PubMed ID: 8590836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
    Falini B; Mason DY
    Blood; 2002 Jan; 99(2):409-26. PubMed ID: 11781220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML
    Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].
    Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Le H; Ruan GR; Liu YR; Huang XJ; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):433-7. PubMed ID: 18072623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias.
    Bao F; Munker R; Lowery C; Martin S; Shi R; Veillon DM; Cotelingam JD; Nordberg ML
    Mol Diagn Ther; 2007; 11(4):239-45. PubMed ID: 17705578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
    Huang W; Cao Q; Lu Y
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
    Langabeer SE; Gale RE; Harvey RC; Cook RW; Mackinnon S; Linch DC
    Leukemia; 2002 Mar; 16(3):393-9. PubMed ID: 11896544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view.
    Miyamura K; Takeo T; Kataoka T; Tahara T; Tanimoto M; Saito H
    Leuk Lymphoma; 1993 Oct; 11(3-4):181-9. PubMed ID: 8260893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment.
    Wandl UB; Bützler R; Niederle N; Kloke O; Mengelkoch B; Becher R; Seeber S; Opalka B
    Leukemia; 1994 May; 8(5):776-9. PubMed ID: 7514245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation.
    Takatsuki H; Umemura T; Sadamura S; Yamashita S; Goto T; Abe Y; Yufu Y; Inaba S; Nishimura J; Nawata H
    Leukemia; 1995 May; 9(5):889-92. PubMed ID: 7539517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
    Arnold R; Janssen JW; Heinze B; Bunjes D; Hertenstein B; Wiesneth M; Kubanek B; Heimpel H; Bartram CR
    Leukemia; 1993 May; 7(5):747-51. PubMed ID: 8483329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.